Anatomic Stage Ii Breast Cancer AJCC V8

AUG 20, 2026 · INTERVENTIONAL STUDY

Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial

ClinicalTrials.gov

This is a terminated study registration with feasibility endpoints only; no results are reported in the registry record, precluding any assessment of efficacy or harm.

AUG 20, 2026 · PHASE 2 TRIAL

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

ClinicalTrials.gov

Phase 2 trial in a recruiting stage with no results reported; measures a surrogate endpoint (ctDNA clearance) in an adjuvant minimal residual disease setting.

AUG 17, 2026 · PHASE 4 TRIAL

Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors

ClinicalTrials.gov

This is a Phase 4 interventional trial registration with no reported results; the study is not yet recruiting and carries planned outcome measures only.

AUG 14, 2026 · INTERVENTIONAL STUDY

A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors

ClinicalTrials.gov

This is a clinical trial registry record describing a planned interventional study with no results posted; it represents the study design and rationale only, not evidence of efficacy.

AUG 11, 2026 · PHASE 3 TRIAL

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

ClinicalTrials.gov

This is an active Phase 3 trial registration with no results posted; the study design is sound but outcome data are not yet available to assess efficacy or safety.

AUG 10, 2026 · PHASE 3 TRIAL

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is still recruiting and has not yet reported outcomes.

AUG 10, 2026 · INTERVENTIONAL STUDY

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

ClinicalTrials.gov

This is a registry record for an active interventional feasibility study with no results yet posted; it describes planned enrollment and outcome measures only, making it a preliminary report of work in progress.